Deep Genomics
Deep Genomics is an AI-driven genetic medicines platform company based in Toronto, Canada. It uses biological foundation models (its BioFM Platform) and lab-integrated AI workflows to discover and develop RNA-based genetic medicines, combining AI model development, high-throughput screening technologies, and information systems to accelerate drug discovery and advance new treatments. Founded by deep learning researcher Brendan Frey, the company is backed by investors including Bloomberg Beta and SoftBank Vision Fund. It surfaces no public developer API, portal, or documentation at this time; this profile tracks the company in the API Evangelist network.
Deep Genomics is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, Genomics, Biotechnology, and Drug Discovery.
Deep Genomics’ developer surface includes engineering blog and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API